Y
Yutong Liu
Researcher at University of Texas at Austin
Publications - 6
Citations - 1031
Yutong Liu is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 2 publications receiving 432 citations.
Papers
More filters
Journal ArticleDOI
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh,Jory A. Goldsmith,Jeffrey M. Schaub,Andrea M. DiVenere,Hung-Che Kuo,Kamyab Javanmardi,Kevin C. Le,Daniel Wrapp,Alison Gene-Wei Lee,Yutong Liu,Chia Wei Chou,Patrick O. Byrne,Christy K. Hjorth,Nicole V. Johnson,John Ludes-Meyers,Annalee W. Nguyen,Juyeon Park,Nianshuang Wang,Dzifa Amengor,Jason J. Lavinder,Gregory C. Ippolito,Jennifer A. Maynard,Ilya J. Finkelstein,Jason S. McLellan +23 more
TL;DR: High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Posted ContentDOI
Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes
Ching-Lin Hsieh,Jory A. Goldsmith,Jeffrey M. Schaub,Andrea M. DiVenere,Hung-Che Kuo,Kamyab Javanmardi,Kevin C. Le,Daniel Wrapp,Alison Gene-Wei Lee,Yutong Liu,Chia-Wei Chou,Patrick O. Byrne,Christy K. Hjorth,Nicole V. Johnson,John Ludes-Meyers,Annalee W. Nguyen,Juyeon Park,Nianshuang Wang,Dzifa Amengor,Jennifer A. Maynard,Ilya J. Finkelstein,Jason S. McLellan +21 more
TL;DR: Over 100 structure-guided spike variants based upon a previously determined cryo-EM structure of the prefusion SARS-CoV-2 spike are designed and expressed, with the best variant, HexaPro, having six beneficial proline substitutions leading to ∼10-fold higher expression than its parental construct.
Journal ArticleDOI
An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH
TL;DR: In this article , the human IgG1 Fc domain was used to enhance pH-selective binding to the receptor FcγRIIIa and subsequent antibody-dependent cellular cytotoxicity (ADCC).
Journal ArticleDOI
Engineering antibodies for conditional activity in the solid tumor microenvironment.
TL;DR: In this article , the authors discuss recent efforts to develop advanced antibody therapeutics with activities restricted to the solid tumor microenvironment, with the intent of decreasing toxicities and expanding therapeutic windows, protein engineering strategies can render ligand binding sensitive to multiple tumor-specific characteristics.
Journal ArticleDOI
Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes
Zimu Li,Yanjun Zhang,Yutong Liu,Jingjing Wang,Banghui Liu,Qiu-Xiang Chen,Qian Wang,Lutang Fu,Peiyi Wang,Xiaolin Zhong,Liang Jin,Ling Chen,Jun He,Jincun Zhao,Xiaoli Xiong +14 more
TL;DR: The identified bound cofactors and structural features that are associated with SARS-CoV-1 S locked conformations are identified and newly determined structures are compared to other available spike structures of Sarbecoviruses to identify conserved features and discuss their possible functions.